BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1805046)

  • 1. Prognostic factors for pleural lymphoma patients.
    Aozasa K; Ohsawa M; Iuchi K; Mori T; Komatsu H; Tajima K; Minato K; Tajima K; Shimoyama M
    Jpn J Clin Oncol; 1991 Dec; 21(6):417-21. PubMed ID: 1805046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Summary of clinical and pathological findings in thirty-seven cases.
    Iuchi K; Aozasa K; Yamamoto S; Mori T; Tajima K; Minato K; Mukai K; Komatsu H; Tagaki T; Kobashi Y
    Jpn J Clin Oncol; 1989 Sep; 19(3):249-57. PubMed ID: 2681886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases.
    Graff-Baker A; Roman SA; Thomas DC; Udelsman R; Sosa JA
    Surgery; 2009 Dec; 146(6):1105-15. PubMed ID: 19958938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax].
    Aozasa K; Ohsawa M
    Rinsho Ketsueki; 1990 May; 31(5):547-53. PubMed ID: 2395206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single unit lymphoma experience: outcome in a Cape Town academic centre.
    Wood L; Robinson R; Gavine L; Juritz J; Jacobs P
    Transfus Apher Sci; 2007 Aug; 37(1):93-102. PubMed ID: 17931976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma.
    Eser B; Sari I; Canoz O; Altuntas F; Cakmak E; Ozturk A; Ozkan M; Er O; Cetin M; Unal A
    Am J Hematol; 2006 May; 81(5):307-14. PubMed ID: 16628716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic features and outcome in patients with diffuse large B-cell lymphoma who do not achieve a complete response to first-line regimens.
    Villela L; López-Guillermo A; Montoto S; Rives S; Bosch F; Perales M; Ferrer A; Esteve J; Colomo L; Campo E; Montserrat E
    Cancer; 2001 Apr; 91(8):1557-62. PubMed ID: 11301405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
    Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
    Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome and prognostic factors in ocular adnexal lymphoma.
    Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
    Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major prognostic factors of adult patients with advanced B-cell lymphoma treated with vincristine, cyclophosphamide, prednisone and doxorubicin (VEPA) or VEPA plus methotrexate (VEPA-M).
    Shimoyama M; Ota K; Kikuchi M; Yunoki K; Konda S; Takatsuki K; Ogawa M; Tominaga S; Tsugane S; Minato K
    Jpn J Clin Oncol; 1988 Jun; 18(2):113-24. PubMed ID: 3379782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics and prognosis of diffuse large B-cell lymphoma].
    Yang BY; Yong WB; Zhu J; Zheng W; Zhang YT; Wang XP; Meng SN
    Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):174-6. PubMed ID: 15946571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of CD44v6 in diffuse large B-cell lymphoma.
    Inagaki H; Banno S; Wakita A; Ueda R; Eimoto T
    Mod Pathol; 1999 May; 12(5):546-52. PubMed ID: 10349995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary Epstein-Barr virus-related non-Hodgkin's lymphoma of the pleural cavity following long-standing tuberculous empyema.
    Molinie V; Pouchot J; Navratil E; Aubert F; Vinceneux P; Barge J
    Arch Pathol Lab Med; 1996 Mar; 120(3):288-91. PubMed ID: 8629908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas.
    Hallermann C; Niermann C; Fischer RJ; Schulze HJ
    J Am Acad Dermatol; 2007 Apr; 56(4):588-97. PubMed ID: 17289214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predicting long-term survival in low-risk diffuse large B-cell lymphoma.
    Møller MB; Pedersen NT; Christensen BE
    Am J Hematol; 2003 Oct; 74(2):94-8. PubMed ID: 14508794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal epidural involvement in pleural lymphomas developing from long-standing tuberculous pyothorax or pleuritis.
    Yasuda N; Ohmori S; Usui T
    Int J Hematol; 1993 Oct; 58(3):177-82. PubMed ID: 8148495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in primary gastric lymphoma.
    Medina-Franco H; Germes SS; Maldonado CL
    Ann Surg Oncol; 2007 Aug; 14(8):2239-45. PubMed ID: 17546474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive model for prognosis in advanced diffuse histiocytic lymphoma.
    Danieu L; Wong G; Koziner B; Clarkson B
    Cancer Res; 1986 Oct; 46(10):5372-9. PubMed ID: 3530438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors influencing survival in patients with B-cell small lymphocytic lymphoma.
    Nola M; Pavletic SZ; Weisenburger DD; Smith LM; Bast MA; Vose JM; Armitage JO
    Am J Hematol; 2004 Sep; 77(1):31-5. PubMed ID: 15307103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.